UK-based ECI Partners has sold healthcare IT company CliniSys to Montagu Private Equity. The exit has yielded ECI a 2.5X return on its investment.
2 min read · 04 July 2013
Dutch biotechnology company Prosensa Holding has started its first trading day on the Nasdaq New York, US. Prosensa is the second Idinvest portfolio company completing a market listing this year. Earlier in 2013, Erytech Pharma, a French company specialized in innovative therapeutic approach for cancers was admitted on NYSE Euronext Paris.
1 min read · 04 July 2013
Standard & Poor's Global Fixed Income Research has conducted a study to estimate the size and structure of the rated US corporate debt market. The sample consists of US corporate instruments totaling $6.59 trillion, as of March 31, 2013.
3 min read · 04 July 2013
Northzone has led a 9.5 million pound ($14.5 million) investment in Ocapo Limited. The technology investor was joined by Chris Hong, who will also serve as CEO, and BOOST&Co, who provided additional debt and equity funding.
2 min read · 04 July 2013
The Private Equity Foundation and Impetus Trust have merged creating a new registered charity Impetus – The Private Equity Foundation. Global private equity firm Warburg Pincus has made a three-year commitment to support the venture.
3 min read · 04 July 2013
Happy Independence Day! For those of you wanting to catch up on the latest private equity and venture capital news links today we have PE giants eyeing up UK's Card Factory; reasons why you shouldn't accept money from a VC and it may be a US holiday but eBay isn't sleeping.
1 min read · 04 July 2013
Technology-related buyouts, distressed deals and European buyouts are bringing in the top dollars for the $255 billion California Public Employees’ Retirement System as of Dec. 31, 2012.
2 min read · 03 July 2013
BelHealth Investment Partners has acquired Linden Care. Linden Care, headquartered in Syosset, NY, provides specialty pharmacy services to the pain management industry.
3 min read · 03 July 2013
France-based Idinvest Partners has acquired a stake in KLS Partners. At the same time KLS is launching its second fund Kurma Biofund II.
2 min read · 03 July 2013
Life science company Arch Therapeutics has appointed Dr. Avtar Dhillon as board chair and Dr. Arthur Rosenthal as director. The company has also appointed Dr. Terrence W. Norchi as president & CEO.
5 min read · 03 July 2013
